End‐to‐End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation
Salvatore Mascia(Massachusetts Institute of Technology), Bernhardt L. Trout(IIT@MIT), Paul I. Barton(Massachusetts Institute of Technology), Timothy F. Jamison(Massachusetts Institute of Technology), Allan S. Myerson(Massachusetts Institute of Technology), Patrick L. Heider(Massachusetts Institute of Technology), Klavs F. Jensen(Massachusetts Institute of Technology), Brahim Benyahia(Massachusetts Institute of Technology), Richard D. Braatz(Massachusetts Institute of Technology), Haitao Zhang(Massachusetts Institute of Technology), Charles L. Cooney(IIT@MIT), James M. B. Evans(Massachusetts Institute of Technology), Richard Lakerveld(Massachusetts Institute of Technology)
Cited by 599
Related Papers
Recent advances in homogeneous nickel catalysis
|Nature|2014|2.3k
Water electrolysis: from textbook knowledge to the latest scientific strategies and industrial developments
|Chemical Society Reviews|2022|1.8k
A robotic platform for flow synthesis of organic compounds informed by AI planning
|Science|2019|1.1k
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
|Science|2016|936
A graph-convolutional neural network model for the prediction of chemical reactivity
|Chemical Science|2018|695